Third-Party Allotment of Shares to LtG Capital
TL Genomics Co., Ltd. conducted a capital increase through a third-party allotment of shares subscribed by LtG Capital Partners LLC, the CVC fund of KAWATA Construction. The company plans to use the funds raised to obtain manufacturing and marketing approval and insurance coverage for an in vitro diagnostic product for chimerism testing, as well as to expand sales of its LOX test.